NovoCure Limited
NVCR
$12.43
$0.524.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -170.95M | -164.19M | -168.63M | -149.78M | -168.70M |
| Total Depreciation and Amortization | 10.96M | 10.38M | 9.87M | 9.58M | 9.93M |
| Total Amortization of Deferred Charges | 5.14M | 5.14M | 5.14M | 4.59M | 4.59M |
| Total Other Non-Cash Items | 124.58M | 122.61M | 130.90M | 84.25M | 82.53M |
| Change in Net Operating Assets | -14.41M | -4.40M | -3.65M | 13.90M | 4.49M |
| Cash from Operations | -44.68M | -30.46M | -26.37M | -37.48M | -67.17M |
| Capital Expenditure | -35.72M | -41.68M | -42.86M | -40.73M | -37.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.22M | -351.25M | -97.39M | 21.20M | 24.84M |
| Cash from Investing | 17.50M | -392.93M | -140.24M | -19.53M | -12.47M |
| Total Debt Issued | 0.00 | 96.92M | 96.92M | 96.92M | 96.92M |
| Total Debt Repaid | 0.00 | -12.91M | -12.91M | -12.91M | -12.91M |
| Issuance of Common Stock | 10.42M | 11.34M | 6.31M | 5.53M | 6.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.42M | 95.35M | 90.32M | 89.54M | 90.61M |
| Foreign Exchange rate Adjustments | 451.00K | 109.00K | -174.00K | 154.00K | -30.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.31M | -327.93M | -76.47M | 32.69M | 10.95M |